SEARCH
NEWS & EVENTS
News Archive
CURRENT NEWS
February 4, 2013
Morphotek Inc. Pilot Plant Receives 2013 Facility of the Year Award
January 10, 2013
Morphotek Announces Top-Line Results of A Phase III Study of Farletuzumab in Patients With Relapsed Platinum-Sensitive Epithelial Ovarian Cancer
November 11, 2012
FDA Grants Orphan Drug Status to Morphotek's Amatuximab (MORAb-009)
August 26, 2012
MORPHOTEK®, INC. ANNOUNCES INITIATION OF MORAb-004 PHASE II STUDY IN METASTATIC SOFT TISSUE SARCOMA
August 14, 2012
Morphotek, Inc. Opens 60,000-Square-Foot Manufacturing Plant
May 30, 2012
Morphotek Earns Prestigious Award for Innovation in Assay Development
May 11, 2012
Morphotek, Inc. Participates in the Fourth Annual Philadelphia Ronald McDonald House Plane Pull
April 16, 2012
Morphotek, Inc. Announces Initiation of MORAb-004 Phase 2 Study in Metastatic Colorectal Cancer